7-64978571-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015852.5(ZNF117):āc.1000A>Gā(p.Lys334Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,460,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015852.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERV3-1-ZNF117 | NM_001348050.2 | c.1000A>G | p.Lys334Glu | missense_variant | 4/4 | NP_001334979.1 | ||
ZNF117 | NM_015852.5 | c.1000A>G | p.Lys334Glu | missense_variant | 4/4 | NP_056936.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF117 | ENST00000282869.11 | c.1000A>G | p.Lys334Glu | missense_variant | 4/4 | 1 | ENSP00000282869.5 | |||
ZNF117 | ENST00000620222.4 | c.1000A>G | p.Lys334Glu | missense_variant | 3/3 | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000404 AC: 1AN: 247816Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134634
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460938Hom.: 0 Cov.: 57 AF XY: 0.00000826 AC XY: 6AN XY: 726768
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.1000A>G (p.K334E) alteration is located in exon 4 (coding exon 2) of the ZNF117 gene. This alteration results from a A to G substitution at nucleotide position 1000, causing the lysine (K) at amino acid position 334 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at